SurModics (SRDX) Reports Q1 Loss, Misses Revenue Estimates
Portfolio Pulse from
SurModics (SRDX) reported a Q1 loss of $0.04 per share, which was better than the expected loss of $0.08 per share. However, the company missed revenue estimates.
January 30, 2025 | 2:30 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
SurModics reported a Q1 loss of $0.04 per share, better than the expected loss of $0.08, but missed revenue estimates. This mixed result may lead to short-term volatility in the stock price.
The better-than-expected EPS loss suggests some positive aspects in cost management or other areas, but missing revenue estimates indicates potential challenges in sales or market conditions. This mixed result can lead to uncertainty and short-term volatility in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100